Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy.
about
Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapyNeuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in strokeUpregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.Therapeutic Strategies for Oxidative Stress-Related Cardiovascular Diseases: Removal of Excess Reactive Oxygen Species in Adult Stem CellsCirculating and tissue resident endothelial progenitor cellsCirculating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.Hypoxia-induced endothelial progenitor cell function is blunted in angiotensinogen knockout mice.Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetesAngiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway.The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke.Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke.ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease TherapyAngiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathwaysEndothelial progenitor cells and neural progenitor cells synergistically protect cerebral endothelial cells from Hypoxia/reoxygenation-induced injury via activating the PI3K/Akt pathwayConcise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and ChallengesMultilayer Membranes of Glycosaminoglycans and Collagen I Biomaterials Modulate the Function and Microvesicle Release of Endothelial Progenitor Cells.The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathwayEffects of endothelial progenitor cell-derived microvesicles on hypoxia/reoxygenation-induced endothelial dysfunction and apoptosis.Intradialytic aerobic cycling exercise alleviates inflammation and improves endothelial progenitor cell count and bone density in hemodialysis patients.Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration.Neuronal over-expression of ACE2 protects brain from ischemia-induced damageCerebroprotective action of angiotensin peptides in stroke.Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.MicroRNA-125a-5p alleviates the deleterious effects of ox-LDL on multiple functions of human brain microvessel endothelial cells.ACE2-EPC-EXs protect ageing ECs against hypoxia/reoxygenation-induced injury through the miR-18a/Nox2/ROS pathway.Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models.MicroRNA-126 Priming Enhances Functions of Endothelial Progenitor Cells under Physiological and Hypoxic Conditions and Their Therapeutic Efficacy in Cerebral Ischemic Damage.
P2860
Q26823609-2AB465DA-B58C-47F2-A6AD-9D6FD4731B32Q26998948-7A14E224-5571-4C1C-8456-663348543D1FQ27308039-241075F0-2DCC-4DC6-B5D9-A14DB12C35A1Q28077974-30E42FCD-C652-41FF-8FE0-1AE02EC4D9C7Q28293322-FE0F1593-1430-4ACE-9EDD-4C67F5C347A5Q30392417-498FF4A7-BCAE-41C3-883B-4B30AF82CAE4Q33861718-9431F666-F92F-43F7-8285-CA7982609AE9Q34111573-CEB48984-76D6-46E5-8566-DD777B5CE41AQ34559574-75310638-6D51-4236-97E7-01AAB95BC0FFQ34811358-996A31EE-4965-46F4-8ACF-946032061B90Q35104883-0C958063-FAC3-4103-8DAD-C4105165902FQ35738095-9E18D0D7-B61A-458D-9C70-8FE73DBDA067Q35760437-25274BD8-3BFB-4226-BCE0-0FAEF1ED7546Q35875449-49520A8A-8313-44CB-880D-AF18B6C29D59Q36537288-F6D79434-D8AD-493E-9A0E-AD289D9640CCQ36703043-7A30B4E8-4266-4653-AC68-D66B337DE38FQ36840791-A633FC59-4556-4D32-B899-808D1AB1C260Q36975014-D251E017-6916-4A13-B545-45A9402FFC1CQ37316289-B28994FE-3305-4EDD-821F-71176DC00CDFQ37328140-A61E971E-8C57-41E6-B310-50A274A56BCEQ37549578-93A80CFB-A57D-4DB5-A4E3-0F23777FE35DQ37712468-08BB4B08-FF9F-477F-ABA3-2D679EC25197Q38150360-4F706096-C0A4-49FD-9788-AC3B52D45868Q38193206-AF6657D7-1AE8-430C-9FBD-B9949503A8C3Q41055983-FAD054B3-9355-41F3-BC6F-C171508AD923Q46452149-272523B8-66D8-4952-9708-0D768DE88280Q48176579-1AC09003-1788-4184-9120-9927AEA6A609Q50035033-94AB8651-9E53-42A0-9D94-44885D433D38Q55089042-0BC2BB05-20B2-491F-A147-E7F0714776BA
P2860
Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@ast
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@en
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@nl
type
label
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@ast
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@en
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@nl
prefLabel
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@ast
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@en
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@nl
P2093
P2860
P1433
P1476
Angiotensin-converting enzyme ...... nd their therapeutic efficacy.
@en
P2093
Cheng Zhang
Jianying Chen
Mohan K Raizada
Shuzhen Chen
Vinayak Shenoy
Xiang Xiao
Yanfang Chen
P2860
P304
P356
10.1161/HYPERTENSIONAHA.111.00202
P407
P577
2012-12-24T00:00:00Z